Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,420.00
-40.00 (-0.73%)
Last updated: Mar 28, 2025

Kwang Dong Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Other Revenue
----0-
Upgrade
Revenue
1,640,7191,514,4541,431,5451,338,1821,243,770
Upgrade
Revenue Growth (YoY)
8.34%5.79%6.98%7.59%0.45%
Upgrade
Cost of Revenue
1,343,7371,216,5631,151,5501,065,870987,672
Upgrade
Gross Profit
296,982297,891279,995272,312256,098
Upgrade
Selling, General & Admin
246,225233,331225,167213,458196,462
Upgrade
Research & Development
10,12815,2759,6788,3225,957
Upgrade
Other Operating Expenses
2,0591,9891,3911,5892,857
Upgrade
Operating Expenses
266,885255,821241,751227,376209,507
Upgrade
Operating Income
30,09742,07038,24444,93646,591
Upgrade
Interest Expense
-10,274-6,904-3,735-2,544-2,539
Upgrade
Interest & Investment Income
6,3195,3992,8442,4152,850
Upgrade
Earnings From Equity Investments
767.76-429.82-435.51-112.22-62.65
Upgrade
Currency Exchange Gain (Loss)
3,159-384.816.49693.27-800.07
Upgrade
Other Non Operating Income (Expenses)
-1,169-179.121,132-865.71932.94
Upgrade
EBT Excluding Unusual Items
28,90039,57138,05644,52246,972
Upgrade
Gain (Loss) on Sale of Investments
25,3999,412-1,932-10,23217,536
Upgrade
Gain (Loss) on Sale of Assets
3,026-1,964166.5238.871,178
Upgrade
Asset Writedown
-----2,735
Upgrade
Pretax Income
57,32549,01936,29134,32962,951
Upgrade
Income Tax Expense
15,4809,6489,5908,78817,349
Upgrade
Earnings From Continuing Operations
41,84539,37226,70125,54145,602
Upgrade
Minority Interest in Earnings
-1,364-2,406-2,527-1,522-232.19
Upgrade
Net Income
40,48136,96624,17424,01945,370
Upgrade
Net Income to Common
40,48136,96624,17424,01945,370
Upgrade
Net Income Growth
9.51%52.91%0.65%-47.06%96.76%
Upgrade
Shares Outstanding (Basic)
4040414141
Upgrade
Shares Outstanding (Diluted)
4040414141
Upgrade
Shares Change (YoY)
-1.10%-1.44%-0.11%1.48%2.24%
Upgrade
EPS (Basic)
1011.00913.00588.45584.681119.49
Upgrade
EPS (Diluted)
1011.00913.00588.00584.331119.00
Upgrade
EPS Growth
10.73%55.27%0.63%-47.78%92.36%
Upgrade
Free Cash Flow
-87,883-46,51537,43931,14517,566
Upgrade
Free Cash Flow Per Share
-2194.85-1148.87911.36757.27433.44
Upgrade
Dividend Per Share
--100.000100.000100.000
Upgrade
Dividend Growth
----25.00%
Upgrade
Gross Margin
18.10%19.67%19.56%20.35%20.59%
Upgrade
Operating Margin
1.83%2.78%2.67%3.36%3.75%
Upgrade
Profit Margin
2.47%2.44%1.69%1.80%3.65%
Upgrade
Free Cash Flow Margin
-5.36%-3.07%2.61%2.33%1.41%
Upgrade
EBITDA
44,62954,97452,26259,04566,299
Upgrade
EBITDA Margin
2.72%3.63%3.65%4.41%5.33%
Upgrade
D&A For EBITDA
14,53212,90414,01714,11019,709
Upgrade
EBIT
30,09742,07038,24444,93646,591
Upgrade
EBIT Margin
1.83%2.78%2.67%3.36%3.75%
Upgrade
Effective Tax Rate
27.00%19.68%26.43%25.60%27.56%
Upgrade
Advertising Expenses
45,51346,18642,21440,46437,872
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.